Anita Brikman: Advancing Plasma-Derived Therapies in India Through Global Collaboration
Anita Brikman, President and CEO of the Plasma Protein Therapeutics Association (PPTA), shared a post on LinkedIn:
“India is an emerging partner in strengthening the global ecosystem for plasma-derived therapies and transfusion medicine.
That’s why this week, on behalf of the Plasma Protein Therapeutics Association (PPTA), Joshua Penrod and I are joining Ranjeet Ajmani to meet with regulators, public health experts, blood bank leaders, patient advocates, clinicians, and plasma fractionation professionals across the country.
Our first day included an inspiring meeting with Madhur Gupta and her team at World Health Organization India; they’ve committed to a five-year action plan for implementing blood component therapy and safety standards (including for recovered plasma) across India’s 4,500 plus blood banks.
Our meeting with Central Drugs Standard Control Organization, Drugs Controller General of India, was also helpful in understanding the regulatory path of plasma-derived medicines in India.
Another influential regulatory force is the Indian Pharmacopoeia Commission (IPC); major updates initiated this year align the IPC’s blood product quality and safety monographs to align with international best practice — a critical step forward in the region.
Thank you to M Kalaivani for hosting PPTA.
Collaboration across borders is how we ensure patients everywhere benefit from the life-enabling power of plasma.
Grateful to the many partners across India who are welcoming us and helping move this important work forward.
I look forward to sharing more as our journey continues.”
Stay updated with Hemostasis Today.
-
Apr 20, 2026, 12:14Yanki Yarman: Linking Genetic Variants to Clinical Outcomes in Thrombosis
-
Apr 20, 2026, 12:09Syed Sibtain Raza: White Blood Cells – Understanding Morphology for Better Diagnosis
-
Apr 20, 2026, 11:23Bastu Odoka: Jehovah’s Witness News on Transfusion… and a Question Worth Asking
-
Apr 20, 2026, 11:15William Aird: A Physiological Approach to Anemia
-
Apr 20, 2026, 10:59Eric Topol: Is the Interferon Pathway a Key Driver of Inflammaging and Aging
-
Apr 20, 2026, 10:47Emmanuel J Favaloro: Emerging Perspectives on Extracellular Vesicles in Hemophilia
-
Apr 20, 2026, 10:21Pierpaolo Di Micco: Honored to Join the ESVM Congress in Lausanne
-
Apr 20, 2026, 08:17Heghine Khachatryan: Key Takeaways from Day 1 – WFH 2026 World Congress
-
Apr 20, 2026, 08:10Justin Nelson-Deering։ Celebrating World Hemophilia Day in Pediatric Care